[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-EP1102769,2003,B1
[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-EP1102769,2003,B1
259147-67-6
681443-02-7
33537-78-9
31314-32-6
36808-17-0
73469-52-0
26723-60-4 | 3-Chloro-6,11-dihydro-5,5-dioxo-11-hydroxy-6-methyldibenzo[c,f][1,2]thiazepine | AA00I4Z4 | MFCD07368144
276695-40-0 | [Benzyl-(4-chloro-benzenesulfonyl)-amino]-acetic acid | AA00I559 | MFCD01168173
294877-43-3 | 1-(3-Bromophenyl)pyrazole-4-carbaldehyde | AA00I5DO | MFCD12134478
303146-25-0 | Methyl 6-chloro-5-cyano-2-methylnicotinate | AA00I5MB | MFCD01315275
3159-04-4 | 2-Chlorodibenzo[b,f][1,4]thiazepin-11(10h)-one | AA00I5WR | MFCD22495113
3254-16-8 | 3,4,6-Tri-o-acetyl-a-d-glucopyranose-1,2-(methyl orthoacetate) | AA00I631 | MFCD09750816
329794-00-5 | [5-(trifluoromethyl)pyridin-2-yl]thiourea | AA00I68X | MFCD20921616
3364-78-1 | 2-Chloromethyl-thiazole | AA00I6JS | MFCD07778428
344338-13-2 | Methyl 3-{[(4-methylbenzene)sulfonyl]oxy}cyclobutane-1-carboxylate | AA00I6Q8 | MFCD28397289
352305-38-5 | Disulfide, bis(2-azidoethyl) | AA00I6WP | MFCD24458414